
Aster DM Healthcare India
Separated in 2024, the Indian business of Aster is a leading integrated healthcare provider offering a network of hospitals, clinics, pharmacies, diagnostic labs, and digital health solutions across India.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | $183m | Post IPO Equity |
Total Funding | 000k |
INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | (1 %) | 19 % | 16 % | (69 %) | 12 % | 16 % | 23 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 13 % | 15 % | 14 % | 37 % | 22 % | 20 % | 21 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 2 % | 5 % | 4 % | 3 % | 130 % | 9 % | 11 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
The story begins in 1987, not in India, but in Dubai. Dr. Azad Moopen, a physician and entrepreneur, established a single clinic with a vision to provide quality healthcare. This solitary clinic was the seed for what would grow into Aster DM Healthcare, a network spanning hospitals, clinics, and pharmacies. The company's Indian entity was formally incorporated in 2008, setting the stage for a dual-market presence. A key turning point for the company was its Initial Public Offering (IPO) in February 2018, listing on Indian stock exchanges. This event provided the capital for further expansion and solidified its position in the public markets. The business operated an integrated model across the GCC and India, leveraging its presence in the Gulf to support growth in its home country. Recently, Aster DM Healthcare went through a significant strategic shift. In 2024, the company completed the separation of its India and GCC businesses. A consortium of investors acquired a majority stake in the GCC operations, while the founding Moopen family retained a significant stake in both the independent Indian and GCC entities. This demerger was designed to allow each business to focus on its distinct market and unlock further value, positioning the Indian arm to concentrate on its domestic growth and expansion plans.
Tech stack
Investments by Aster DM Healthcare India
Edit

